" BEIJING Cheap Anthony Mason Shirt , Dec. 11 (Xinhua) -- The Asian Infrastructure Investment Bank (AIIB) announced Monday that it has approved its first loan in China for a natural gas project.
The 250-million-U.S. dollar loan will fund a project to connect 216,750 households in approximately 510 villages to the natural gas distribution network, according to an AIIB statement.
Upon completion and after subtracting the emissions from burning natural gas, the project is expected to reduce annual carbon dioxide emissions by 595,700 tonnes Cheap Tracy McGrady Shirt , particulate matter by 3,700 tonnes, sulfur dioxide by 1,488 tonnes and nitrogen oxide by 4,442 tonnes Cheap John Starks Shirt , according to the statement.
AIIB President Jin Liqun said China's commitment to reducing its reliance on coal will change lives and improve the environment.
""That is why we are investing in a project aligned with their ambitious plan,"" Jin added.
He reaffirmed AIIB's ""unwavering commitment"" to helping members meet their environmental and development goals, especially their commitments under the Paris Agreement.
""It is only fitting that our first investment in China will introduce sustainable infrastructure that will reduce greenhouse gas emissions and help invigorate one of the most important economic hubs in Asia,"" Jin said.
The investment in the project also marks AIIB's first corporate loan. The project, undertaken by the Beijing Gas Group Company Cheap Kristaps Porzingis Shirt , will entail construction of natural gas distribution networks in villages and low-pressure gas pipelines and household connections. It is scheduled for completion in 2021.
" Operational Strategies of Global Cancer Immunotherapies Market to $103.4 billion in 2024
by chhidami12 · January 21, 2019
Researchmoz added Most up-to-date research on “Global Cancer Immunotherapies Market to 2024 – Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline” to its huge collection of research reports.
Global Cancer Immunotherapies Market to 2024 – Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large Cheap Tim Hardaway Jr. Shirt , Robust Pipeline
Summary
Cancer immunotherapy, which can predominantly be classed as a form of targeted therapy, drives an immune response against cancer cells. This may include stimulating a patients immune system in a general way or aiding the identification of specific antigens associated with the cancer.
The interest in cancer immunotherapy development has been driven by the growing understanding of the immune system as a hallmark of cancer pathophysiology, particularly immune evasion of developing cancer cells. Overall, 3 Cheap Enes Kanter Shirt ,863 products are being actively developed in the cancer immunotherapy pipeline, approximately half of the overall oncology pipeline.
To Get Sample Copy of Report visit @ ;repid=1877886
The report focuses on the key indications of breast cancer, leukemia, lymphoma, melanoma and non-small cell lung cancer Cheap Patrick Ewing Shirt , these indications are the largest in terms of size, with 448, 526, 456, 415 and 374 in active development Cheap Carmelo Anthony Shirt , respectively. The pipeline is dominated mAbs, cell therapies, small molecules and cancer vaccines.
Scope
– Global revenue from the cancer immunotherapies market is forecast to increase from $33.7 billion in 2017 to $103.4 billion in 2024, at a compound annual growth rate of 17.4%. What is driving this growth? – The leading companies in terms of market share are Celgene, Merck & Co. Cheap Joakim Noah Jersey , Bristol-Myers Squibb and Roche. Which of these are forecast to experience the largest growth? – There are some key new approvals and late-stage products set to enter the market during the forecast period. Which impact will these drugs have on the market? – The market has been dominated by immune checkpoint inhibitors and drugs that target tumor associated antigens. To what extent will these classes of drugs and others dominate the market over the forecast period? – There are 3,863 cancer immunotherapy products in the pipeline. What molecular targets are most abundant in the pipeline and what role will pipeline product approvals play in market growth? – Cancer immunotherapy clinical trials have an overall attrition rate of around 96%, what can companies do to maximize their chance of success?
Get Complete TOC With Tables and Figures @
Reasons to buy
– Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drugs mechanism of action. – Analyze the cancer immunotherapy pipeline through a comprehensive review of the pipeline segmented by stage of development Cheap Frank Ntilikina Jersey , molecule type and molecular target. This review also provides a detailed look at current cancer immunotherapies to provide an insight into the risk associated of attempting to bring pipeline products to market. – Predict growth in market size, with in-depth market forecasting from 2017 to 2024. The forecasts will provide an understanding of how epidemiology trends, new drug entries, and certain patent expirations will influence market value. – Identify commercial opportunities in the cancer immunotherapies deals landscape by analyzing trends in licensing and co-development deals
Problems & Solutions
Thema drucken
01.04.2019 08:09
Antworten
